Mingyi  Shang

Dr. Mingyi Shang


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 March 2022 in Cellular Signalling
Verified
Journal Article
Closed access
XYXiang Yin
Xiang Yin
PZPeng Zhang
Peng Zhang
NXNing Xia
Ning Xia
SWShaoqiu Wu
Shaoqiu Wu
BLBingyan Liu
Bingyan Liu
MSMingyi Shang
Mingyi Shang

4 July 2022 in Cellular Signalling
Verified
Journal Article
Closed access
SWShaoqiu Wu
Shaoqiu Wu
XYXiang Yin
Xiang Yin
NXNing Xia
Ning Xia
PZPeng Zhang
Peng Zhang
BLBingyan Liu
Bingyan Liu
MSMingyi Shang
Mingyi Shang

11 November 2025 in Journal of Translational Medicine
Verified
Journal Article
Open access
PDF file
YAYan An
Yan An
XSXiangyang Shi
Xiangyang Shi
WHWentao Huang
Wentao Huang
MSMingyi Shang
Mingyi Shang
GJGuang-Zhi Jin
Guang-Zhi Jin
Hepatocellular carcinoma (HCC) is one of the most prevalent malignancies, and the treatment options are limited. Growing evidence shows that long non-coding RNAs (LncRNAs) encode peptides, suggesting that lncRNAs-derived peptides may play a role in HCC progression and explore their potential as therapeutic targets. We used RNA-sequencing and bioinformatics analysis to identify a 107-amino acid peptide, SMIM45-107aa, encoded by LINC00634. The expression levels and prognostic significance of SMIM45-107aa in HCC tissues were assessed by immunohistochemistry (IHC) and Kaplan-Meier. Wound-healing and cell colony formation evaluate the effects of SMIM45-107aa on cell migration and proliferation. A mouse xenograft model was used to examine the tumor formation. Interactions between SMIM45-107aa and MTDH were explored and the effects on MTDH ubiquitination were investigated by immunoprecipitation. Proteomic analysis and Western blotting confirmed the mechanism of SMIM45-107aa effected HCC. Additionally, a short peptide, peptide 5 derived from SMIM45-107aa was analyzed by cell migration in SK-Hep1 cells and by zebrafish model. SMIM45-107aa was highly expressed in HCC tissues and associated with poor prognosis. It promoted cell migration and proliferation in vitro and tumor formation in vivo. SMIM45-107aa interacted with MTDH, inhibiting its ubiquitination and stabilizing the protein. Proteomic and Western blot analysis revealed that SMIM45-107aa upregulated MGST1 and phosphorylated AKT (pAKT). Importantly, peptide 5 inhibited SMIM45-107aa-induced cell migration and demonstrated anticancer activity in zebrafish models. We identified SMIM45-107aa, a novel peptide encoded by LINC00634, which promoted HCC progression via the MGST1-pAKT-MTDH axis. The derived peptide 5 exhibited anticancer activity, suggesting a potential therapeutic strategy for HCC.

14 March 2026 in Acta Biomaterialia
Verified
Journal Article
Closed access
SMShutao Ma
Shutao Ma
MSMingyi Shang
Mingyi Shang
XYXiang Yin
Xiang Yin
MEMohamed El-Newehy
Mohamed El-Newehy
MAMeera Moydeen Abdulhameed
Meera Moydeen Abdulhameed
Xiumei MoXiumei Mo
Xiumei Mo